Human umbilical cord-derived mesenchymal stem cell therapy (Guangzhou Bio-Gene Technology)

人脐带间充质干细胞（广州百暨基因科技）

Report date: 2026/04/10 10:38:19

Base Information

Drug NameHuman umbilical cord-derived mesenchymal stem cell therapy (Guangzhou Bio-Gene Technology)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesGuangzhou Bio-Gene Technology Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGuangzhou Bio-Gene Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A